nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS1—kidney cancer	0.428	0.636	CbGaD
Diflunisal—PTGS2—kidney cancer	0.245	0.364	CbGaD
Diflunisal—TTR—urine—kidney cancer	0.0097	0.257	CbGeAlD
Diflunisal—UGT1A8—renal system—kidney cancer	0.00517	0.137	CbGeAlD
Diflunisal—UGT1A8—kidney—kidney cancer	0.005	0.132	CbGeAlD
Diflunisal—PTGS2—nephron—kidney cancer	0.00421	0.111	CbGeAlD
Diflunisal—SLC22A6—nephron tubule—kidney cancer	0.00267	0.0707	CbGeAlD
Diflunisal—TTR—renal system—kidney cancer	0.00237	0.0628	CbGeAlD
Diflunisal—TTR—kidney—kidney cancer	0.0023	0.0607	CbGeAlD
Diflunisal—SLC22A6—cortex of kidney—kidney cancer	0.00229	0.0605	CbGeAlD
Diflunisal—PTGS1—renal system—kidney cancer	0.000864	0.0228	CbGeAlD
Diflunisal—PTGS1—kidney—kidney cancer	0.000835	0.0221	CbGeAlD
Diflunisal—PTGS2—renal system—kidney cancer	0.000825	0.0218	CbGeAlD
Diflunisal—Olsalazine—PTGS1—kidney cancer	0.000817	0.136	CrCbGaD
Diflunisal—PTGS2—kidney—kidney cancer	0.000798	0.0211	CbGeAlD
Diflunisal—PTGS1—cardiac atrium—kidney cancer	0.000773	0.0205	CbGeAlD
Diflunisal—Aminosalicylic Acid—PTGS1—kidney cancer	0.000768	0.128	CrCbGaD
Diflunisal—Salsalate—PTGS1—kidney cancer	0.000694	0.116	CrCbGaD
Diflunisal—Mesalazine—PTGS1—kidney cancer	0.000603	0.1	CrCbGaD
Diflunisal—Olsalazine—PTGS2—kidney cancer	0.000467	0.0779	CrCbGaD
Diflunisal—Aminosalicylic Acid—PTGS2—kidney cancer	0.000439	0.0732	CrCbGaD
Diflunisal—Salicylic acid—PTGS1—kidney cancer	0.000427	0.0712	CrCbGaD
Diflunisal—Salsalate—PTGS2—kidney cancer	0.000397	0.0662	CrCbGaD
Diflunisal—Flurbiprofen—PTGS1—kidney cancer	0.000374	0.0624	CrCbGaD
Diflunisal—Mesalazine—PTGS2—kidney cancer	0.000344	0.0574	CrCbGaD
Diflunisal—Fatigue—Sunitinib—kidney cancer	0.000263	0.00118	CcSEcCtD
Diflunisal—Asthenia—Everolimus—kidney cancer	0.000262	0.00117	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000262	0.00117	CcSEcCtD
Diflunisal—Constipation—Sunitinib—kidney cancer	0.000261	0.00117	CcSEcCtD
Diflunisal—Gastrointestinal pain—Sorafenib—kidney cancer	0.00026	0.00116	CcSEcCtD
Diflunisal—Renal failure—Capecitabine—kidney cancer	0.00026	0.00116	CcSEcCtD
Diflunisal—Pruritus—Everolimus—kidney cancer	0.000259	0.00116	CcSEcCtD
Diflunisal—Anaphylactic shock—Vincristine—kidney cancer	0.000258	0.00116	CcSEcCtD
Diflunisal—Oedema—Vincristine—kidney cancer	0.000258	0.00116	CcSEcCtD
Diflunisal—Stomatitis—Capecitabine—kidney cancer	0.000257	0.00115	CcSEcCtD
Diflunisal—Jaundice—Capecitabine—kidney cancer	0.000257	0.00115	CcSEcCtD
Diflunisal—Chest pain—Gemcitabine—kidney cancer	0.000256	0.00114	CcSEcCtD
Diflunisal—Asthenia—Erlotinib—kidney cancer	0.000253	0.00113	CcSEcCtD
Diflunisal—Thrombocytopenia—Vincristine—kidney cancer	0.000253	0.00113	CcSEcCtD
Diflunisal—Urticaria—Sorafenib—kidney cancer	0.000252	0.00113	CcSEcCtD
Diflunisal—Haematuria—Capecitabine—kidney cancer	0.000252	0.00113	CcSEcCtD
Diflunisal—Photosensitivity—Doxorubicin—kidney cancer	0.000252	0.00113	CcSEcCtD
Diflunisal—Decreased appetite—Dactinomycin—kidney cancer	0.000251	0.00112	CcSEcCtD
Diflunisal—Diarrhoea—Vinblastine—kidney cancer	0.000251	0.00112	CcSEcCtD
Diflunisal—Body temperature increased—Sorafenib—kidney cancer	0.000251	0.00112	CcSEcCtD
Diflunisal—Diarrhoea—Everolimus—kidney cancer	0.00025	0.00112	CcSEcCtD
Diflunisal—Gastrointestinal pain—Sunitinib—kidney cancer	0.00025	0.00112	CcSEcCtD
Diflunisal—Hyperhidrosis—Vincristine—kidney cancer	0.00025	0.00112	CcSEcCtD
Diflunisal—Pruritus—Erlotinib—kidney cancer	0.00025	0.00112	CcSEcCtD
Diflunisal—Fatigue—Dactinomycin—kidney cancer	0.000249	0.00112	CcSEcCtD
Diflunisal—Flatulence—Paclitaxel—kidney cancer	0.000248	0.00111	CcSEcCtD
Diflunisal—Tension—Paclitaxel—kidney cancer	0.000247	0.0011	CcSEcCtD
Diflunisal—Agranulocytosis—Capecitabine—kidney cancer	0.000246	0.0011	CcSEcCtD
Diflunisal—Anorexia—Vincristine—kidney cancer	0.000246	0.0011	CcSEcCtD
Diflunisal—Oedema—Gemcitabine—kidney cancer	0.000245	0.0011	CcSEcCtD
Diflunisal—Anaphylactic shock—Gemcitabine—kidney cancer	0.000245	0.0011	CcSEcCtD
Diflunisal—Nervousness—Paclitaxel—kidney cancer	0.000244	0.00109	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—kidney cancer	0.000244	0.0407	CrCbGaD
Diflunisal—Dizziness—Vinblastine—kidney cancer	0.000243	0.00109	CcSEcCtD
Diflunisal—Dizziness—Everolimus—kidney cancer	0.000242	0.00108	CcSEcCtD
Diflunisal—Muscle spasms—Paclitaxel—kidney cancer	0.000242	0.00108	CcSEcCtD
Diflunisal—Body temperature increased—Sunitinib—kidney cancer	0.000242	0.00108	CcSEcCtD
Diflunisal—Diarrhoea—Erlotinib—kidney cancer	0.000241	0.00108	CcSEcCtD
Diflunisal—Thrombocytopenia—Gemcitabine—kidney cancer	0.00024	0.00107	CcSEcCtD
Diflunisal—Feeling abnormal—Dactinomycin—kidney cancer	0.000238	0.00107	CcSEcCtD
Diflunisal—Hepatitis—Capecitabine—kidney cancer	0.000237	0.00106	CcSEcCtD
Diflunisal—Vision blurred—Paclitaxel—kidney cancer	0.000237	0.00106	CcSEcCtD
Diflunisal—Hyperhidrosis—Gemcitabine—kidney cancer	0.000237	0.00106	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000237	0.00106	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000234	0.00105	CcSEcCtD
Diflunisal—Hypersensitivity—Sorafenib—kidney cancer	0.000234	0.00105	CcSEcCtD
Diflunisal—Insomnia—Vincristine—kidney cancer	0.000234	0.00105	CcSEcCtD
Diflunisal—Anorexia—Gemcitabine—kidney cancer	0.000234	0.00105	CcSEcCtD
Diflunisal—Vomiting—Vinblastine—kidney cancer	0.000233	0.00104	CcSEcCtD
Diflunisal—Dizziness—Erlotinib—kidney cancer	0.000233	0.00104	CcSEcCtD
Diflunisal—Vomiting—Everolimus—kidney cancer	0.000233	0.00104	CcSEcCtD
Diflunisal—Renal impairment—Doxorubicin—kidney cancer	0.000232	0.00104	CcSEcCtD
Diflunisal—Paraesthesia—Vincristine—kidney cancer	0.000232	0.00104	CcSEcCtD
Diflunisal—Rash—Everolimus—kidney cancer	0.000231	0.00103	CcSEcCtD
Diflunisal—Dermatitis—Everolimus—kidney cancer	0.00023	0.00103	CcSEcCtD
Diflunisal—Headache—Vinblastine—kidney cancer	0.00023	0.00103	CcSEcCtD
Diflunisal—Angioedema—Paclitaxel—kidney cancer	0.00023	0.00103	CcSEcCtD
Diflunisal—Headache—Everolimus—kidney cancer	0.000229	0.00103	CcSEcCtD
Diflunisal—Body temperature increased—Dactinomycin—kidney cancer	0.000229	0.00102	CcSEcCtD
Diflunisal—Visual impairment—Capecitabine—kidney cancer	0.000228	0.00102	CcSEcCtD
Diflunisal—Asthenia—Sorafenib—kidney cancer	0.000228	0.00102	CcSEcCtD
Diflunisal—Vertigo—Paclitaxel—kidney cancer	0.000226	0.00101	CcSEcCtD
Diflunisal—Syncope—Paclitaxel—kidney cancer	0.000226	0.00101	CcSEcCtD
Diflunisal—Hypersensitivity—Sunitinib—kidney cancer	0.000225	0.00101	CcSEcCtD
Diflunisal—Decreased appetite—Vincristine—kidney cancer	0.000225	0.001	CcSEcCtD
Diflunisal—Pruritus—Sorafenib—kidney cancer	0.000225	0.001	CcSEcCtD
Diflunisal—Vomiting—Erlotinib—kidney cancer	0.000224	0.001	CcSEcCtD
Diflunisal—Erythema multiforme—Capecitabine—kidney cancer	0.000224	0.001	CcSEcCtD
Diflunisal—Fatigue—Vincristine—kidney cancer	0.000223	0.000997	CcSEcCtD
Diflunisal—Rash—Erlotinib—kidney cancer	0.000223	0.000995	CcSEcCtD
Diflunisal—Dermatitis—Erlotinib—kidney cancer	0.000222	0.000995	CcSEcCtD
Diflunisal—Palpitations—Paclitaxel—kidney cancer	0.000222	0.000994	CcSEcCtD
Diflunisal—Insomnia—Gemcitabine—kidney cancer	0.000222	0.000992	CcSEcCtD
Diflunisal—Headache—Erlotinib—kidney cancer	0.000221	0.000989	CcSEcCtD
Diflunisal—Tinnitus—Capecitabine—kidney cancer	0.000221	0.000989	CcSEcCtD
Diflunisal—Loss of consciousness—Paclitaxel—kidney cancer	0.000221	0.000989	CcSEcCtD
Diflunisal—Constipation—Vincristine—kidney cancer	0.000221	0.000989	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000221	0.000988	CcSEcCtD
Diflunisal—Paraesthesia—Gemcitabine—kidney cancer	0.00022	0.000985	CcSEcCtD
Diflunisal—Flushing—Capecitabine—kidney cancer	0.00022	0.000984	CcSEcCtD
Diflunisal—Asthenia—Sunitinib—kidney cancer	0.000219	0.000981	CcSEcCtD
Diflunisal—Dyspnoea—Gemcitabine—kidney cancer	0.000219	0.000978	CcSEcCtD
Diflunisal—Nausea—Vinblastine—kidney cancer	0.000218	0.000976	CcSEcCtD
Diflunisal—Somnolence—Gemcitabine—kidney cancer	0.000218	0.000975	CcSEcCtD
Diflunisal—Nausea—Everolimus—kidney cancer	0.000217	0.000972	CcSEcCtD
Diflunisal—Diarrhoea—Sorafenib—kidney cancer	0.000217	0.000972	CcSEcCtD
Diflunisal—Pruritus—Sunitinib—kidney cancer	0.000216	0.000967	CcSEcCtD
Diflunisal—Chest pain—Paclitaxel—kidney cancer	0.000214	0.000958	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—kidney cancer	0.000214	0.0357	CrCbGaD
Diflunisal—Decreased appetite—Gemcitabine—kidney cancer	0.000213	0.000953	CcSEcCtD
Diflunisal—Hypersensitivity—Dactinomycin—kidney cancer	0.000213	0.000953	CcSEcCtD
Diflunisal—Fatigue—Gemcitabine—kidney cancer	0.000211	0.000945	CcSEcCtD
Diflunisal—Gastrointestinal pain—Vincristine—kidney cancer	0.000211	0.000945	CcSEcCtD
Diflunisal—Dizziness—Sorafenib—kidney cancer	0.00021	0.000939	CcSEcCtD
Diflunisal—Constipation—Gemcitabine—kidney cancer	0.00021	0.000938	CcSEcCtD
Diflunisal—Nausea—Erlotinib—kidney cancer	0.00021	0.000938	CcSEcCtD
Diflunisal—Diarrhoea—Sunitinib—kidney cancer	0.000209	0.000935	CcSEcCtD
Diflunisal—Salicylic acid—ABCB1—kidney cancer	0.000208	0.0346	CrCbGaD
Diflunisal—Asthenia—Dactinomycin—kidney cancer	0.000208	0.000928	CcSEcCtD
Diflunisal—Confusional state—Paclitaxel—kidney cancer	0.000207	0.000926	CcSEcCtD
Diflunisal—Oedema—Paclitaxel—kidney cancer	0.000205	0.000918	CcSEcCtD
Diflunisal—Anaphylactic shock—Paclitaxel—kidney cancer	0.000205	0.000918	CcSEcCtD
Diflunisal—Body temperature increased—Vincristine—kidney cancer	0.000204	0.000914	CcSEcCtD
Diflunisal—Flatulence—Capecitabine—kidney cancer	0.000203	0.00091	CcSEcCtD
Diflunisal—Dizziness—Sunitinib—kidney cancer	0.000202	0.000904	CcSEcCtD
Diflunisal—Feeling abnormal—Gemcitabine—kidney cancer	0.000202	0.000904	CcSEcCtD
Diflunisal—Shock—Paclitaxel—kidney cancer	0.000202	0.000903	CcSEcCtD
Diflunisal—Vomiting—Sorafenib—kidney cancer	0.000202	0.000903	CcSEcCtD
Diflunisal—Thrombocytopenia—Paclitaxel—kidney cancer	0.000201	0.000899	CcSEcCtD
Diflunisal—Rash—Sorafenib—kidney cancer	0.0002	0.000896	CcSEcCtD
Diflunisal—Dermatitis—Sorafenib—kidney cancer	0.0002	0.000895	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000199	0.00089	CcSEcCtD
Diflunisal—Headache—Sorafenib—kidney cancer	0.000199	0.00089	CcSEcCtD
Diflunisal—Muscle spasms—Capecitabine—kidney cancer	0.000198	0.000888	CcSEcCtD
Diflunisal—Hyperhidrosis—Paclitaxel—kidney cancer	0.000198	0.000888	CcSEcCtD
Diflunisal—Diarrhoea—Dactinomycin—kidney cancer	0.000198	0.000885	CcSEcCtD
Diflunisal—Anorexia—Paclitaxel—kidney cancer	0.000196	0.000875	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—kidney cancer	0.000196	0.000875	CcSEcCtD
Diflunisal—Vision blurred—Capecitabine—kidney cancer	0.000195	0.00087	CcSEcCtD
Diflunisal—Vomiting—Sunitinib—kidney cancer	0.000194	0.000869	CcSEcCtD
Diflunisal—Body temperature increased—Gemcitabine—kidney cancer	0.000194	0.000867	CcSEcCtD
Diflunisal—Rash—Sunitinib—kidney cancer	0.000193	0.000862	CcSEcCtD
Diflunisal—Dermatitis—Sunitinib—kidney cancer	0.000192	0.000861	CcSEcCtD
Diflunisal—Headache—Sunitinib—kidney cancer	0.000191	0.000856	CcSEcCtD
Diflunisal—Hypersensitivity—Vincristine—kidney cancer	0.00019	0.000852	CcSEcCtD
Diflunisal—Nausea—Sorafenib—kidney cancer	0.000189	0.000844	CcSEcCtD
Diflunisal—Insomnia—Paclitaxel—kidney cancer	0.000186	0.00083	CcSEcCtD
Diflunisal—Vertigo—Capecitabine—kidney cancer	0.000185	0.000829	CcSEcCtD
Diflunisal—Asthenia—Vincristine—kidney cancer	0.000185	0.000829	CcSEcCtD
Diflunisal—Syncope—Capecitabine—kidney cancer	0.000185	0.000828	CcSEcCtD
Diflunisal—Paraesthesia—Paclitaxel—kidney cancer	0.000184	0.000824	CcSEcCtD
Diflunisal—Vomiting—Dactinomycin—kidney cancer	0.000184	0.000823	CcSEcCtD
Diflunisal—Dyspnoea—Paclitaxel—kidney cancer	0.000183	0.000819	CcSEcCtD
Diflunisal—Somnolence—Paclitaxel—kidney cancer	0.000182	0.000816	CcSEcCtD
Diflunisal—Palpitations—Capecitabine—kidney cancer	0.000182	0.000816	CcSEcCtD
Diflunisal—Rash—Dactinomycin—kidney cancer	0.000182	0.000816	CcSEcCtD
Diflunisal—Nausea—Sunitinib—kidney cancer	0.000181	0.000812	CcSEcCtD
Diflunisal—Loss of consciousness—Capecitabine—kidney cancer	0.000181	0.000811	CcSEcCtD
Diflunisal—Dyspepsia—Paclitaxel—kidney cancer	0.000181	0.000808	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—kidney cancer	0.000179	0.000799	CcSEcCtD
Diflunisal—Decreased appetite—Paclitaxel—kidney cancer	0.000178	0.000798	CcSEcCtD
Diflunisal—Fatigue—Paclitaxel—kidney cancer	0.000177	0.000792	CcSEcCtD
Diflunisal—Diarrhoea—Vincristine—kidney cancer	0.000177	0.000791	CcSEcCtD
Diflunisal—Asthenia—Gemcitabine—kidney cancer	0.000176	0.000787	CcSEcCtD
Diflunisal—Chest pain—Capecitabine—kidney cancer	0.000176	0.000786	CcSEcCtD
Diflunisal—Constipation—Paclitaxel—kidney cancer	0.000176	0.000785	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000174	0.00078	CcSEcCtD
Diflunisal—Pruritus—Gemcitabine—kidney cancer	0.000173	0.000776	CcSEcCtD
Diflunisal—Nausea—Dactinomycin—kidney cancer	0.000172	0.000769	CcSEcCtD
Diflunisal—Dizziness—Vincristine—kidney cancer	0.000171	0.000764	CcSEcCtD
Diflunisal—Confusional state—Capecitabine—kidney cancer	0.00017	0.00076	CcSEcCtD
Diflunisal—Feeling abnormal—Paclitaxel—kidney cancer	0.000169	0.000757	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000169	0.000755	CcSEcCtD
Diflunisal—Oedema—Capecitabine—kidney cancer	0.000168	0.000753	CcSEcCtD
Diflunisal—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000168	0.000751	CcSEcCtD
Diflunisal—Diarrhoea—Gemcitabine—kidney cancer	0.000168	0.00075	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—kidney cancer	0.000167	0.000749	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—kidney cancer	0.000166	0.000742	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—kidney cancer	0.000166	0.000742	CcSEcCtD
Diflunisal—Shock—Capecitabine—kidney cancer	0.000166	0.000741	CcSEcCtD
Diflunisal—Thrombocytopenia—Capecitabine—kidney cancer	0.000165	0.000738	CcSEcCtD
Diflunisal—Vomiting—Vincristine—kidney cancer	0.000164	0.000735	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—kidney cancer	0.000163	0.00073	CcSEcCtD
Diflunisal—Urticaria—Paclitaxel—kidney cancer	0.000163	0.000729	CcSEcCtD
Diflunisal—Rash—Vincristine—kidney cancer	0.000163	0.000729	CcSEcCtD
Diflunisal—Hyperhidrosis—Capecitabine—kidney cancer	0.000163	0.000728	CcSEcCtD
Diflunisal—Dermatitis—Vincristine—kidney cancer	0.000163	0.000728	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—kidney cancer	0.000162	0.000726	CcSEcCtD
Diflunisal—Body temperature increased—Paclitaxel—kidney cancer	0.000162	0.000726	CcSEcCtD
Diflunisal—Headache—Vincristine—kidney cancer	0.000162	0.000724	CcSEcCtD
Diflunisal—Anorexia—Capecitabine—kidney cancer	0.000161	0.000718	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—kidney cancer	0.000159	0.000711	CcSEcCtD
Diflunisal—Vomiting—Gemcitabine—kidney cancer	0.000156	0.000697	CcSEcCtD
Diflunisal—Rash—Gemcitabine—kidney cancer	0.000155	0.000691	CcSEcCtD
Diflunisal—Dermatitis—Gemcitabine—kidney cancer	0.000154	0.000691	CcSEcCtD
Diflunisal—Headache—Gemcitabine—kidney cancer	0.000154	0.000687	CcSEcCtD
Diflunisal—Nausea—Vincristine—kidney cancer	0.000154	0.000687	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—kidney cancer	0.000153	0.000684	CcSEcCtD
Diflunisal—Insomnia—Capecitabine—kidney cancer	0.000152	0.000681	CcSEcCtD
Diflunisal—Paraesthesia—Capecitabine—kidney cancer	0.000151	0.000677	CcSEcCtD
Diflunisal—Hypersensitivity—Paclitaxel—kidney cancer	0.000151	0.000676	CcSEcCtD
Diflunisal—Dyspnoea—Capecitabine—kidney cancer	0.00015	0.000672	CcSEcCtD
Diflunisal—Dyspepsia—Capecitabine—kidney cancer	0.000148	0.000663	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—kidney cancer	0.000147	0.000659	CcSEcCtD
Diflunisal—Asthenia—Paclitaxel—kidney cancer	0.000147	0.000659	CcSEcCtD
Diflunisal—Decreased appetite—Capecitabine—kidney cancer	0.000146	0.000655	CcSEcCtD
Diflunisal—Nausea—Gemcitabine—kidney cancer	0.000146	0.000651	CcSEcCtD
Diflunisal—Fatigue—Capecitabine—kidney cancer	0.000145	0.00065	CcSEcCtD
Diflunisal—Pruritus—Paclitaxel—kidney cancer	0.000145	0.00065	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—kidney cancer	0.000145	0.000646	CcSEcCtD
Diflunisal—Constipation—Capecitabine—kidney cancer	0.000144	0.000644	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—kidney cancer	0.000142	0.000637	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—kidney cancer	0.000142	0.000634	CcSEcCtD
Diflunisal—Diarrhoea—Paclitaxel—kidney cancer	0.00014	0.000628	CcSEcCtD
Diflunisal—Feeling abnormal—Capecitabine—kidney cancer	0.000139	0.000621	CcSEcCtD
Diflunisal—Gastrointestinal pain—Capecitabine—kidney cancer	0.000138	0.000616	CcSEcCtD
Diflunisal—Dizziness—Paclitaxel—kidney cancer	0.000136	0.000607	CcSEcCtD
Diflunisal—Urticaria—Capecitabine—kidney cancer	0.000134	0.000599	CcSEcCtD
Diflunisal—Body temperature increased—Capecitabine—kidney cancer	0.000133	0.000596	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—kidney cancer	0.000131	0.000586	CcSEcCtD
Diflunisal—Tension—Doxorubicin—kidney cancer	0.000131	0.000584	CcSEcCtD
Diflunisal—Vomiting—Paclitaxel—kidney cancer	0.000131	0.000584	CcSEcCtD
Diflunisal—Rash—Paclitaxel—kidney cancer	0.000129	0.000579	CcSEcCtD
Diflunisal—Dermatitis—Paclitaxel—kidney cancer	0.000129	0.000578	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—kidney cancer	0.000129	0.000578	CcSEcCtD
Diflunisal—Headache—Paclitaxel—kidney cancer	0.000129	0.000575	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—kidney cancer	0.000128	0.000572	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—kidney cancer	0.000125	0.000561	CcSEcCtD
Diflunisal—Hypersensitivity—Capecitabine—kidney cancer	0.000124	0.000555	CcSEcCtD
Diflunisal—Nausea—Paclitaxel—kidney cancer	0.000122	0.000545	CcSEcCtD
Diflunisal—Asthenia—Capecitabine—kidney cancer	0.000121	0.000541	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—kidney cancer	0.00012	0.000535	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—kidney cancer	0.000119	0.000534	CcSEcCtD
Diflunisal—Pruritus—Capecitabine—kidney cancer	0.000119	0.000533	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—kidney cancer	0.000118	0.000526	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—kidney cancer	0.000117	0.000523	CcSEcCtD
Diflunisal—Diarrhoea—Capecitabine—kidney cancer	0.000115	0.000516	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—kidney cancer	0.000113	0.000507	CcSEcCtD
Diflunisal—Dizziness—Capecitabine—kidney cancer	0.000111	0.000498	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—kidney cancer	0.000109	0.00049	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—kidney cancer	0.000109	0.000486	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—kidney cancer	0.000109	0.000486	CcSEcCtD
Diflunisal—Vomiting—Capecitabine—kidney cancer	0.000107	0.000479	CcSEcCtD
Diflunisal—Shock—Doxorubicin—kidney cancer	0.000107	0.000478	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—kidney cancer	0.000106	0.000476	CcSEcCtD
Diflunisal—Rash—Capecitabine—kidney cancer	0.000106	0.000475	CcSEcCtD
Diflunisal—Dermatitis—Capecitabine—kidney cancer	0.000106	0.000475	CcSEcCtD
Diflunisal—Headache—Capecitabine—kidney cancer	0.000106	0.000472	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—kidney cancer	0.000105	0.00047	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—kidney cancer	0.000104	0.000463	CcSEcCtD
Diflunisal—Nausea—Capecitabine—kidney cancer	0.0001	0.000448	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—kidney cancer	9.82e-05	0.000439	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—kidney cancer	9.75e-05	0.000436	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—kidney cancer	9.68e-05	0.000433	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—kidney cancer	9.65e-05	0.000432	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—kidney cancer	9.56e-05	0.000428	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—kidney cancer	9.44e-05	0.000422	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—kidney cancer	9.36e-05	0.000419	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—kidney cancer	9.29e-05	0.000415	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—kidney cancer	8.95e-05	0.0004	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—kidney cancer	8.88e-05	0.000397	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—kidney cancer	8.63e-05	0.000386	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—kidney cancer	8.58e-05	0.000384	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—kidney cancer	8e-05	0.000358	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—kidney cancer	7.79e-05	0.000348	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—kidney cancer	7.68e-05	0.000344	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—kidney cancer	7.43e-05	0.000332	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—kidney cancer	7.18e-05	0.000321	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—kidney cancer	6.9e-05	0.000309	CcSEcCtD
Diflunisal—Rash—Doxorubicin—kidney cancer	6.85e-05	0.000306	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—kidney cancer	6.84e-05	0.000306	CcSEcCtD
Diflunisal—Headache—Doxorubicin—kidney cancer	6.8e-05	0.000304	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—kidney cancer	6.45e-05	0.000288	CcSEcCtD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	5.01e-05	0.000841	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	4.92e-05	0.000826	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.88e-05	0.000819	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FLT1—kidney cancer	4.86e-05	0.000816	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APRT—kidney cancer	4.83e-05	0.000812	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—FH—kidney cancer	4.83e-05	0.000812	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ACY1—kidney cancer	4.82e-05	0.000809	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	4.78e-05	0.000803	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CCBL1—kidney cancer	4.76e-05	0.000799	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—kidney cancer	4.73e-05	0.000795	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.72e-05	0.000793	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPC3—kidney cancer	4.54e-05	0.000763	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—GRB7—kidney cancer	4.51e-05	0.000758	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	4.51e-05	0.000757	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JUNB—kidney cancer	4.5e-05	0.000756	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PAK1—kidney cancer	4.5e-05	0.000756	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CA2—kidney cancer	4.42e-05	0.000742	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALAD—kidney cancer	4.31e-05	0.000724	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GPC3—kidney cancer	4.31e-05	0.000723	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.31e-05	0.000723	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ST3GAL2—kidney cancer	4.21e-05	0.000706	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ITPR2—kidney cancer	4.2e-05	0.000705	CbGpPWpGaD
Diflunisal—TTR—Disease—HIF1A—kidney cancer	4.18e-05	0.000703	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.18e-05	0.000702	CbGpPWpGaD
Diflunisal—TTR—Disease—TSC2—kidney cancer	4.17e-05	0.000701	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—kidney cancer	4.17e-05	0.000701	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPAT—kidney cancer	4.13e-05	0.000693	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GLIPR1—kidney cancer	4.13e-05	0.000693	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—POMC—kidney cancer	4.12e-05	0.000692	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALDH1A1—kidney cancer	4.11e-05	0.00069	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.11e-05	0.00069	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PDHB—kidney cancer	4.1e-05	0.000688	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.08e-05	0.000684	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	4.06e-05	0.000681	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.03e-05	0.000678	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ST3GAL2—kidney cancer	3.99e-05	0.000669	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.94e-05	0.000662	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC5A3—kidney cancer	3.94e-05	0.000662	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PGK1—kidney cancer	3.94e-05	0.000662	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—LDHB—kidney cancer	3.86e-05	0.000649	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.86e-05	0.000648	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CCBL1—kidney cancer	3.85e-05	0.000647	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APRT—kidney cancer	3.84e-05	0.000644	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—FH—kidney cancer	3.84e-05	0.000644	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.83e-05	0.000643	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.79e-05	0.000636	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.75e-05	0.00063	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PGK1—kidney cancer	3.74e-05	0.000627	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC5A3—kidney cancer	3.74e-05	0.000627	CbGpPWpGaD
Diflunisal—TTR—Disease—APC—kidney cancer	3.69e-05	0.000619	CbGpPWpGaD
Diflunisal—TTR—Disease—KIT—kidney cancer	3.69e-05	0.000619	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IGF2—kidney cancer	3.68e-05	0.000618	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN2B—kidney cancer	3.66e-05	0.000615	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SFRP2—kidney cancer	3.66e-05	0.000615	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LDHB—kidney cancer	3.66e-05	0.000615	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPC3—kidney cancer	3.61e-05	0.000606	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IGF1R—kidney cancer	3.56e-05	0.000598	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CA2—kidney cancer	3.51e-05	0.000589	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.51e-05	0.000589	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.48e-05	0.000585	CbGpPWpGaD
Diflunisal—TTR—Disease—BRAF—kidney cancer	3.46e-05	0.000582	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALAD—kidney cancer	3.42e-05	0.000574	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TCEB1—kidney cancer	3.42e-05	0.000574	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TCEB2—kidney cancer	3.42e-05	0.000574	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CA9—kidney cancer	3.35e-05	0.000563	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.35e-05	0.000562	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GLIPR1—kidney cancer	3.34e-05	0.000561	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPAT—kidney cancer	3.34e-05	0.000561	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.34e-05	0.000561	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.34e-05	0.000561	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.31e-05	0.000556	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.3e-05	0.000554	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—kidney cancer	3.29e-05	0.000552	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.27e-05	0.00055	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.26e-05	0.000548	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.26e-05	0.000548	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.24e-05	0.000544	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.23e-05	0.000542	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC5A3—kidney cancer	3.13e-05	0.000525	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PGK1—kidney cancer	3.13e-05	0.000525	CbGpPWpGaD
Diflunisal—ALB—Metabolism—FH—kidney cancer	3.1e-05	0.000521	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APRT—kidney cancer	3.1e-05	0.000521	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IFNA1—kidney cancer	3.08e-05	0.000517	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—LDHB—kidney cancer	3.07e-05	0.000515	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.03e-05	0.00051	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HIF1A—kidney cancer	2.93e-05	0.000492	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TSC2—kidney cancer	2.92e-05	0.000491	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPC3—kidney cancer	2.92e-05	0.00049	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.92e-05	0.00049	CbGpPWpGaD
Diflunisal—TTR—Disease—RAF1—kidney cancer	2.89e-05	0.000486	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTEN—kidney cancer	2.87e-05	0.000482	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IFNA2—kidney cancer	2.87e-05	0.000481	CbGpPWpGaD
Diflunisal—TTR—Disease—ERBB2—kidney cancer	2.86e-05	0.000481	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.85e-05	0.000479	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CRABP1—kidney cancer	2.85e-05	0.000478	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CA2—kidney cancer	2.84e-05	0.000477	CbGpPWpGaD
Diflunisal—TTR—Disease—MTOR—kidney cancer	2.82e-05	0.000474	CbGpPWpGaD
Diflunisal—TTR—Disease—CD4—kidney cancer	2.82e-05	0.000473	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KDR—kidney cancer	2.8e-05	0.000471	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—kidney cancer	2.8e-05	0.00047	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RPL14—kidney cancer	2.78e-05	0.000466	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALAD—kidney cancer	2.77e-05	0.000465	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.76e-05	0.000463	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.76e-05	0.000463	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.75e-05	0.000462	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ST3GAL2—kidney cancer	2.7e-05	0.000454	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.68e-05	0.000451	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CA9—kidney cancer	2.66e-05	0.000447	CbGpPWpGaD
Diflunisal—TTR—Disease—CDKN1B—kidney cancer	2.65e-05	0.000445	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ITPR2—kidney cancer	2.65e-05	0.000445	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALDH1A1—kidney cancer	2.64e-05	0.000443	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.63e-05	0.000441	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.6e-05	0.000437	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—APC—kidney cancer	2.58e-05	0.000433	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KIT—kidney cancer	2.58e-05	0.000433	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IGF2—kidney cancer	2.58e-05	0.000433	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PGK1—kidney cancer	2.53e-05	0.000425	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC5A3—kidney cancer	2.53e-05	0.000425	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ITPR2—kidney cancer	2.51e-05	0.000422	CbGpPWpGaD
Diflunisal—TTR—Disease—CTNNB1—kidney cancer	2.5e-05	0.00042	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LDHB—kidney cancer	2.48e-05	0.000417	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.48e-05	0.000416	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.47e-05	0.000415	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—POMC—kidney cancer	2.46e-05	0.000413	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.44e-05	0.00041	CbGpPWpGaD
Diflunisal—TTR—Disease—PTEN—kidney cancer	2.44e-05	0.00041	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—BRAF—kidney cancer	2.43e-05	0.000407	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ACHE—kidney cancer	2.42e-05	0.000406	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTT1—kidney cancer	2.42e-05	0.000406	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.37e-05	0.000397	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SCARB1—kidney cancer	2.29e-05	0.000384	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.28e-05	0.000383	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CRABP1—kidney cancer	2.26e-05	0.00038	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PSMD7—kidney cancer	2.22e-05	0.000373	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.2e-05	0.00037	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.17e-05	0.000365	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CA9—kidney cancer	2.15e-05	0.000361	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—BCHE—kidney cancer	2.1e-05	0.000353	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PSMD7—kidney cancer	2.1e-05	0.000353	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.1e-05	0.000353	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ITPR2—kidney cancer	2.1e-05	0.000353	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.1e-05	0.000353	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK3—kidney cancer	2.09e-05	0.00035	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC5A5—kidney cancer	2.08e-05	0.000349	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—kidney cancer	2.03e-05	0.000341	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RAF1—kidney cancer	2.03e-05	0.00034	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—kidney cancer	2.02e-05	0.00034	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RELA—kidney cancer	2.02e-05	0.000339	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC2A1—kidney cancer	2.01e-05	0.000337	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB2—kidney cancer	2e-05	0.000337	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.99e-05	0.000334	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK1—kidney cancer	1.98e-05	0.000333	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MTOR—kidney cancer	1.98e-05	0.000332	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.95e-05	0.000327	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.94e-05	0.000326	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ACHE—kidney cancer	1.92e-05	0.000322	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTT1—kidney cancer	1.92e-05	0.000322	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC2A1—kidney cancer	1.9e-05	0.00032	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.89e-05	0.000317	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JUNB—kidney cancer	1.89e-05	0.000317	CbGpPWpGaD
Diflunisal—TTR—Disease—KRAS—kidney cancer	1.87e-05	0.000315	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1B—kidney cancer	1.86e-05	0.000312	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CRABP1—kidney cancer	1.83e-05	0.000307	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—kidney cancer	1.82e-05	0.000305	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SCARB1—kidney cancer	1.81e-05	0.000305	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTGS1—kidney cancer	1.8e-05	0.000302	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—kidney cancer	1.77e-05	0.000297	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JUN—kidney cancer	1.77e-05	0.000297	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PSMD7—kidney cancer	1.76e-05	0.000296	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CTNNB1—kidney cancer	1.75e-05	0.000294	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—kidney cancer	1.72e-05	0.000289	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—kidney cancer	1.71e-05	0.000287	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ITPR2—kidney cancer	1.7e-05	0.000286	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.7e-05	0.000285	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTP1—kidney cancer	1.67e-05	0.000281	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—BCHE—kidney cancer	1.67e-05	0.000281	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC5A5—kidney cancer	1.65e-05	0.000277	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.64e-05	0.000275	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC2A1—kidney cancer	1.59e-05	0.000268	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ABCB1—kidney cancer	1.58e-05	0.000266	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.57e-05	0.000263	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ACHE—kidney cancer	1.55e-05	0.000261	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTT1—kidney cancer	1.55e-05	0.000261	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—kidney cancer	1.54e-05	0.000259	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—kidney cancer	1.54e-05	0.000258	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN2B—kidney cancer	1.54e-05	0.000258	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SCARB1—kidney cancer	1.47e-05	0.000247	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK3—kidney cancer	1.46e-05	0.000245	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1A1—kidney cancer	1.46e-05	0.000245	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS1—kidney cancer	1.45e-05	0.000244	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PSMD7—kidney cancer	1.43e-05	0.000239	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RAF1—kidney cancer	1.42e-05	0.000239	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—kidney cancer	1.42e-05	0.000238	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK1—kidney cancer	1.39e-05	0.000233	CbGpPWpGaD
Diflunisal—ALB—Metabolism—BCHE—kidney cancer	1.35e-05	0.000227	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.35e-05	0.000226	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC5A5—kidney cancer	1.33e-05	0.000224	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTP1—kidney cancer	1.33e-05	0.000223	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KRAS—kidney cancer	1.31e-05	0.00022	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC2A1—kidney cancer	1.29e-05	0.000216	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—kidney cancer	1.27e-05	0.000214	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ABCB1—kidney cancer	1.26e-05	0.000211	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.25e-05	0.00021	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.23e-05	0.000206	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIF1A—kidney cancer	1.23e-05	0.000206	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TSC2—kidney cancer	1.23e-05	0.000206	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—kidney cancer	1.22e-05	0.000205	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CA—kidney cancer	1.21e-05	0.000202	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.2e-05	0.000201	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—kidney cancer	1.17e-05	0.000196	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1A1—kidney cancer	1.16e-05	0.000194	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.09e-05	0.000183	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—POMC—kidney cancer	1.09e-05	0.000183	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KIT—kidney cancer	1.08e-05	0.000182	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APC—kidney cancer	1.08e-05	0.000182	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—kidney cancer	1.08e-05	0.000182	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTP1—kidney cancer	1.08e-05	0.000181	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK3—kidney cancer	1.02e-05	0.000172	CbGpPWpGaD
Diflunisal—PTGS2—Disease—BRAF—kidney cancer	1.02e-05	0.000171	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCB1—kidney cancer	1.02e-05	0.000171	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—kidney cancer	9.88e-06	0.000166	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK1—kidney cancer	9.74e-06	0.000164	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.51e-06	0.00016	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1A1—kidney cancer	9.37e-06	0.000157	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KRAS—kidney cancer	9.2e-06	0.000155	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—kidney cancer	8.67e-06	0.000146	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—POMC—kidney cancer	8.63e-06	0.000145	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RAF1—kidney cancer	8.5e-06	0.000143	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—kidney cancer	8.45e-06	0.000142	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB2—kidney cancer	8.41e-06	0.000141	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTOR—kidney cancer	8.3e-06	0.000139	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD4—kidney cancer	8.28e-06	0.000139	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—kidney cancer	8.18e-06	0.000137	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1B—kidney cancer	7.79e-06	0.000131	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.7e-06	0.000129	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—kidney cancer	7.56e-06	0.000127	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CTNNB1—kidney cancer	7.36e-06	0.000124	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—kidney cancer	7.17e-06	0.00012	CbGpPWpGaD
Diflunisal—ALB—Metabolism—POMC—kidney cancer	6.98e-06	0.000117	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK3—kidney cancer	6.13e-06	0.000103	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—kidney cancer	6e-06	0.000101	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—kidney cancer	5.96e-06	0.0001	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK1—kidney cancer	5.83e-06	9.79e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—kidney cancer	5.57e-06	9.35e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KRAS—kidney cancer	5.51e-06	9.25e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—kidney cancer	5.34e-06	8.96e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—kidney cancer	5.06e-06	8.49e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—kidney cancer	4.86e-06	8.16e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—kidney cancer	4.24e-06	7.11e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—kidney cancer	3.43e-06	5.76e-05	CbGpPWpGaD
